$368.60
-6.40[-1.71%]
At close: Apr 25
$368.60
0[0.00%]
After Hours: 5:31PM EDT
Latest News for argenx Stock (NASDAQ:ARGX)
argenx Stock (NASDAQ: ARGX)
Categories: All
Thursday, April 18, 2024
- The Analyst Verdict: argenx In The Eyes Of 12 ExpertsBenzinga Insights - Apr 18, 2024, 10:01AM
- Wedbush Reiterates Outperform on argenx, Maintains $521 Price TargetBenzinga Newsdesk - Apr 18, 2024, 9:21AM
- HC Wainwright & Co. Reiterates Buy on argenx, Maintains $451 Price TargetBenzinga Newsdesk - Apr 18, 2024, 6:41AM
Tuesday, April 16, 2024
Wednesday, April 10, 2024
Wednesday, March 27, 2024
Tuesday, March 26, 2024
- Key Takeaways From argenx Analyst RatingsBenzinga Insights - Mar 26, 2024, 3:01PM
- Tesla To $120? Here Are 10 Top Analyst Forecasts For TuesdayAvi Kapoor - Mar 26, 2024, 8:30AM
- Scotiabank Maintains Sector Perform on argenx, Raises Price Target to $408Benzinga Newsdesk - Mar 26, 2024, 7:24AM
- argenx Receives Approval Of VYVGART In Japan For Adults With Primary Immune ThrombocytopeniaBenzinga Newsdesk - Mar 26, 2024, 3:15AM
Friday, March 22, 2024
Thursday, March 21, 2024
- Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Mar 21, 2024, 2:39PM
- Guess? Posts Upbeat Earnings, Joins Lufax, Nortech Systems And Other Big Stocks Moving Higher On ThursdayAvi Kapoor - Mar 21, 2024, 1:58PM
- Why Is European Pharma Giant Argenx Valued At Over $20B Trading Higher On Thursday?Vandana Singh - Mar 21, 2024, 11:06AM
- Argenx shares are trading higher after myasthenia gravis data from competitors Chugai and Roche fell short of expectations.Benzinga Newsdesk - Mar 21, 2024, 9:12AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Mar 21, 2024, 9:05AM
- Why Micron Therapies Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Mar 21, 2024, 8:05AM
Tuesday, March 05, 2024
Friday, March 01, 2024
- Scotiabank Maintains Sector Perform on argenx, Raises Price Target to $402Benzinga Newsdesk - Mar 1, 2024, 12:12PM
- JMP Securities Maintains Market Outperform on argenx, Raises Price Target to $471Benzinga Newsdesk - Mar 1, 2024, 11:34AM
- Baird Maintains Outperform on argenx, Lowers Price Target to $490Benzinga Newsdesk - Mar 1, 2024, 7:47AM
- HC Wainwright & Co. Reiterates Buy on argenx, Maintains $451 Price TargetBenzinga Newsdesk - Mar 1, 2024, 7:05AM
Thursday, February 29, 2024
- argenx shares are trading lower following Q4 results.Benzinga Newsdesk - Feb 29, 2024, 10:38AM
- Earnings Scheduled For February 29, 2024Benzinga Insights - Feb 29, 2024, 5:15AM
- argenx For 2024 Expects Combined Research And Development And Selling, General And Administrative Expenses To Be Less Than $2BBenzinga Newsdesk - Feb 29, 2024, 2:00AM
- argenx Q4 EPS $(1.68) Beats $(1.71) Estimate, Sales $417.84M Beat $364.75M EstimateBenzinga Newsdesk - Feb 29, 2024, 1:56AM
Tuesday, February 20, 2024
Thursday, February 15, 2024
Monday, February 05, 2024
Friday, January 26, 2024
Thursday, January 18, 2024
- Halozyme's Ambitious Five-Year Plan: Analysts Optimistic On Growth, Eyeing Market ExpansionVandana Singh - Jan 18, 2024, 1:28PM
- Piper Sandler Maintains Overweight on argenx, Raises Price Target to $518Benzinga Newsdesk - Jan 18, 2024, 12:45PM
- argenx Announces Approval Of VYVDURA® Injection For Subcutaneous Use In Japan For Generalized Myasthenia GravisBenzinga Newsdesk - Jan 18, 2024, 2:36AM
Wednesday, January 17, 2024
Wednesday, December 27, 2023
Thursday, December 21, 2023
- Argenx's Autoimmune Trial Stumble: Analysts Cut Price Targets, Warn of Risky OutcomesVandana Singh - Dec 21, 2023, 2:41PM
- Evercore ISI Group Maintains Outperform on argenx, Lowers Price Target to $436Benzinga Newsdesk - Dec 21, 2023, 11:54AM
- Scotiabank Maintains Sector Perform on argenx, Lowers Price Target to $346Benzinga Newsdesk - Dec 21, 2023, 11:47AM
- Truist Securities Maintains Buy on argenx, Lowers Price Target to $370-Report Released on 20 December 2023Benzinga Newsdesk - Dec 21, 2023, 10:38AM
- Truist Securities Maintains Buy on argenx, Lowers Price Target to $370Benzinga Newsdesk - Dec 21, 2023, 10:37AM
- Piper Sandler Maintains Overweight on argenx, Lowers Price Target to $515Benzinga Newsdesk - Dec 21, 2023, 9:27AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Dec 21, 2023, 8:07AM
- Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For ThursdayAvi Kapoor - Dec 21, 2023, 7:36AM
- Wells Fargo Maintains Overweight on argenx, Lowers Price Target to $470Benzinga Newsdesk - Dec 21, 2023, 6:19AM
- HC Wainwright & Co. Maintains Buy on argenx, Lowers Price Target to $451Benzinga Newsdesk - Dec 21, 2023, 6:11AM
- Raymond James Maintains Strong Buy on argenx, Lowers Price Target to $520Benzinga Newsdesk - Dec 21, 2023, 4:36AM